Active Ingredient
Salicylic Acid 17%
The following Structured Product Label (SPL) was submitted to the FDA by The Tetra Corporation for the product Glycylic (NDC 49406-009). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, keep out of reach of children, directions, inactive ingredients, product label, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Salicylic Acid 17%
Wart Remover
for the removal of common and plantar warts. The common wart is easily recognized by the rough 'cauliflower-like' appearance of the surface. The plantar wart exists only on the bottom of the foot and interrupts footprint pattern.
FOR EXTERNAL USE ONLY.
Flammable
• keep away from fire or flame.
•
cap bottle tightly and store at room temperature away from heat.
Do not use
• if you are a diabetic or have poor blood circulation, except under the advice and supervision of a doctor or podiatrist.
• irritated, infected or reddened skin.
• genital warts and warts on the face.
• moles, birthmarks and warts with hair growing from them.
• mucous membranes.
When using this product
• avoid contact with eyes. If product gets into the eyes, flush with water for 15 minutes.
• avoid inhaling vapors.
Stop use and ask doctor if
• discomfort persists.
If swallowed, get medical help or contact a Poison Control Center right away.
• wash affected area, may soak wart in warm water for 5 minutes
• dry area thoroughly
• apply small amount of wart remover with applicator to sufficiently cover each wart
• let dry and repeat this procedure once or twice daily until wart is removed for up to 12 weeks
Collodion USP, SDA-40-B 200pf, Glycerin USP, Ethoxydiglycol (Transcutol/Carbitol), Glycolic Acid 70%, Ethyl Pyruvate, Povidone/Iodine USP
* Please review the disclaimer below.